Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber; Savino Sciascia; Ian N Bruce; Ian Giles; Maria J Cuadrado; Hannah Cohen; Caroline Gordon; David Isenberg; Søren Jacobsen; Saskia Middeldorp; Marta Mosca; Sue Pavord; Massimo Radin; Dario Roccatello; Jane Salmon; Evélyne Vinet; Anne Voss; Linda Watkins; Beverley J Hunt

doi:10.1016/S2665-9913(20)30382-9

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber, Savino Sciascia, Ian N Bruce, Ian Giles, Maria J Cuadrado, Hannah Cohen, Caroline Gordon, David Isenberg, Søren Jacobsen, Saskia Middeldorp, Marta Mosca, Sue Pavord, Massimo Radin, Dario Roccatello, Jane Salmon, Evélyne Vinet, Anne Voss, Linda Watkins, Beverley J Hunt

Center for Rheumatology and Spine Diseases

3 Citations (Scopus)

Original language	English
Journal	The Lancet Rheumatology
Volume	2
Issue number	12
Pages (from-to)	e735-e736
ISSN	2665-9913
DOIs	https://doi.org/10.1016/S2665-9913(20)30382-9
Publication status	Published - Dec 2020

Access to Document

10.1016/S2665-9913(20)30382-9

Cite this

Schreiber, K., Sciascia, S., Bruce, I. N., Giles, I., Cuadrado, M. J., Cohen, H., Gordon, C., Isenberg, D., Jacobsen, S., Middeldorp, S., Mosca, M., Pavord, S., Radin, M., Roccatello, D., Salmon, J., Vinet, E., Voss, A., Watkins, L., & Hunt, B. J. (2020). Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians. The Lancet Rheumatology, 2(12), e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

Schreiber, K, Sciascia, S, Bruce, IN, Giles, I, Cuadrado, MJ, Cohen, H, Gordon, C, Isenberg, D, Jacobsen, S, Middeldorp, S, Mosca, M, Pavord, S, Radin, M, Roccatello, D, Salmon, J, Vinet, E, Voss, A, Watkins, L & Hunt, BJ 2020, 'Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians', The Lancet Rheumatology, vol. 2, no. 12, pp. e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

@article{3e5ec2e3937249efb8b4491eb17c81b6,

title = "Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians",

author = "Karen Schreiber and Savino Sciascia and Bruce, {Ian N} and Ian Giles and Cuadrado, {Maria J} and Hannah Cohen and Caroline Gordon and David Isenberg and S{\o}ren Jacobsen and Saskia Middeldorp and Marta Mosca and Sue Pavord and Massimo Radin and Dario Roccatello and Jane Salmon and Ev{\'e}lyne Vinet and Anne Voss and Linda Watkins and Hunt, {Beverley J}",

year = "2020",

month = dec,

doi = "10.1016/S2665-9913(20)30382-9",

language = "English",

volume = "2",

pages = "e735--e736",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic

T2 - a letter to clinicians

AU - Schreiber, Karen

AU - Sciascia, Savino

AU - Bruce, Ian N

AU - Giles, Ian

AU - Cuadrado, Maria J

AU - Cohen, Hannah

AU - Gordon, Caroline

AU - Isenberg, David

AU - Jacobsen, Søren

AU - Middeldorp, Saskia

AU - Mosca, Marta

AU - Pavord, Sue

AU - Radin, Massimo

AU - Roccatello, Dario

AU - Salmon, Jane

AU - Vinet, Evélyne

AU - Voss, Anne

AU - Watkins, Linda

AU - Hunt, Beverley J

PY - 2020/12

Y1 - 2020/12

U2 - 10.1016/S2665-9913(20)30382-9

DO - 10.1016/S2665-9913(20)30382-9

M3 - Letter

C2 - 33163976

VL - 2

SP - e735-e736

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

SN - 2665-9913

IS - 12

ER -